Moxifloxacin Misom Labs (Moxifloxacin Hydrochloride)

Moxifloxacin Hydrochloride, the active ingredient in Moxifloxacin Misom Labs, is a fluoroquinolone antibiotic presented as an ophthalmic preparation for ocular use. It treats bacterial conjunctivitis, bacterial keratitis and other ocular bacterial infections in patients requiring topical therapy.

GNH USA supplies Moxifloxacin Misom Labs as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxifloxacin Misom Labs is a fluoroquinolone antibiotic used to manage bacterial infections of the eye. - Bacterial conjunctivitis: reduces bacterial load and accelerates resolution of redness and discharge. - Bacterial keratitis: eradicates pathogenic bacteria to prevent corneal damage and preserve vision. - Other ocular bacterial infections: treats infections such as blepharitis and ulcerative keratopathy caused by susceptible organisms.

Moxifloxacin Misom Labs may cause ocular and systemic adverse reactions.

Common Side Effects: - Stinging or burning upon instillation. - Redness of the conjunctiva. - Transient blurred vision. - Mild eye irritation. - Temporary increased tear production.

Serious or Rare Side Effects: - Corneal epithelial toxicity or ulceration. - Severe allergic reaction (e.g., angioedema, anaphylaxis). - Persistent visual disturbance. - Secondary ocular infection. - Tendon rupture (systemic exposure).

Before using Moxifloxacin Misom Labs, consider the following safety measures. - Hypersensitivity: avoid if the patient has known allergy to fluoroquinolones or any component of the eye drop. - Corneal health: monitor patients with pre‑existing corneal epithelial defects. - Systemic absorption: use caution in patients on systemic fluoroquinolones to prevent additive toxicity. - Pregnancy and lactation: assess risk‑benefit as safety data are limited. - Storage: Store at room temperature: keep in the original container, protect from light and moisture.

Moxifloxacin Misom Labs can interact with other ophthalmic agents and systemic medications.

Major Interactions (Avoid): - Concurrent use with other fluoroquinolone eye drops: may increase risk of ocular toxicity. - Co‑administration with topical corticosteroids: can mask signs of infection.

Moderate Interactions (Monitor Closely): - Systemic fluoroquinolones: potential additive systemic exposure. - Non‑steroidal anti‑inflammatory eye drops: may exacerbate corneal irritation. - Anticholinergic eye preparations: could affect tear film stability. - Contact lens wear: advise removal before instillation to reduce drug absorption variability.